ERA-EDTA Council and the ERACODA Working Group* Correspondence to: Alberto Ortiz, E-mail: AOrtiz@fjd.es*A list of members of the ERA-EDTA Council and the ERACODA Working Group can be found as Acknowledgements section.
Read More
Jennifer Duplessie
LARGEST KIDNEY GROUP THANKS PRESIDENT TRUMP FOR SIGNING PANDEMIC RELIEF AND TRANSPLANT DRUG COVERAGE
Transplant Drug Reform A Milestone in First Year of AAKP’s Decade of the Kidney Washington, D.C.: The American Association of Kidney Patients (AAKP), the largest and oldest kidney patient organization in the United States, released the following statement upon President Donald J.
Read More
KIDNEY PATIENTS HAIL U.S. SENATE MOVE ON TRANSPLANT DRUGS
FOR IMMEDIATE RELEASE: December 21, 2020 MEDIA CONTACTS: Jennifer Duplessie, Marketing and Communications Manager jduplessie@aakp.org (512) 659-8818 Diana Clynes, Executive Director dclynes@aakp.org (727) 916-0390 KIDNEY PATIENTS HAIL U.S.
Read More
December 16, 2020: AAKP & AST joint letter to FDA on importance of supporting rational clinical trial design and support for kidney transplant desensitization
December 16, 2020 Nikolay P. Nikolov, MDDirector, Division of Rheumatology and Transplant MedicineFood and Drug AdministrationCenter for Drug Evaluation and ResearchDivision of Rheumatology and Transplant Medicine5901-B Ammendale RoadBeltsville, MD 20705-1266Re:
Read More
Kidney Patients Making National Impact Helping Patients During National Pandemic
World Kidney News/Urban Health Outreach Media hosted a special broadcast featuring the executive leadership of the American Association of Kidney Patients: Diana Clynes, Executive Director; Richard Knight, President; Edward V. Hickey, III, U.S.M.C., Vice President, Chair of AAKP Veterans Health Initiative; and Paul T.
Read More
TOP KIDNEY GROUP SALUTES CONGRESSIONAL ACTION ON TRANSPLANT DRUGS FOR PATIENTS
FOR IMMEDIATE RELEASE: December 9, 2020 TOP KIDNEY GROUP SALUTES CONGRESSIONAL ACTION ON TRANSPLANT DRUGS FOR PATIENTS AAKP Calls for Immediate Senate Action, Asks President Trump to Sign Upon Passage Washington, D.C.: The American Association of Kidney Patients (AAKP) released the following statement regarding the U.S.
Read More
AAKP Innovator Series: Dr. Ray Harris
You are very well known across the larger kidney community for leadership, medical expertise, and respect for patient insights. For AAKP readers, can you tell us how patients have informed your view of medicine, and your role as a thought leader in kidney medicine and kidney innovation?
Read More
AAKP, ASTS, AST letter to Congress expressing concerns about BETTER Kidney Care Act – November 2020
November 23, 2020 Congressman Earl Blumenauer Congressman Jason Smith 1111 Longworth House Office Building 2418 Rayburn House Office Building Washington, D.C.
Read More
November 13, 2020 – Partnership to Improve Patient Care (PIPC) letter commenting on PCORI’s Proposed Principles for the Consideration of the Full Range of Outcomes Data
November 13, 2020 Nakela Cook, MD, MPHExecutive DirectorPatient-Centered Outcomes Research Institute1828 L Street NW, Suite 900Washington, DC 20036 Dear Dr. Cook:We are writing to comment on PCORI’s Proposed Principles for the Consideration of the Full Range of Outcomes Data.
Read More
KIDNEY ADVOCATES RECOGNIZED FOR NATIONAL COVID-19 RESPONSE EFFORTS
FOR IMMEDIATE RELEASE:November 9, 2020 KIDNEY ADVOCATES EARN PRESIDENT’S SERVICE AWARDS FOR COVID-19 EFFORTS Tampa, FL: Today, the American Association of Kidney Patients (AAKP)
Read More
